XM은(는) 미국 국적의 시민에게 서비스를 제공하지 않습니다.

Biden is not being treated for Parkinson's, White House says after NYT report



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>UPDATE 4-Biden is not being treated for Parkinson's, White House says after NYT report</title></head><body>

Adds details of White House doctor's letter in paragraphs 3, 6, Biden's comment to MSNBC in paragraph 4

WASHINGTON, July 8 (Reuters) -U.S. President Joe Biden is not being treated for Parkinson's disease and has not seen a neurologist outside of his annual physicals, the White House said on Monday, after the New York Times reported that visitor logs showed a doctor specializing in the illness visited the White House at least eight times from August through March.

Concerns that Biden might be suffering from an undisclosed illness have risen since he stumbled, appearing frail and losing his train of thought at times, at his June 27 debate against Republican Donald Trump.

Dr. Kevin O'Connor, the White House doctor, issued a letter on Monday night that said Biden has not seen a neurologist outside of his normal annual physical.

Biden is battling criticism from some Democrats that he lacks the mental acuity to stand as their nominee against Trump in the Nov. 5 presidential election. Biden has, however, said he will not abandon his campaign, telling MSNBC via phone on Monday that he was "not going anywhere".

A Reuters review of White House visitor logs showed that Dr. Kevin Cannard, a neurologist and movement disorders specialist from Walter Reed National Military Medical Center, visited the White House eight times from August through March. Cannard has co-authored research on treatment for early Parkinson's disease at Vanderbilt University Medical Center.

O'Connor said Cannard's visits to the White House were part of his neurological clinics aimed at supporting "thousands" of active duty members assigned in support of White House operations and not to treat the president.

Cannard's visits to the White House were first reported by The New York Post on July 6.

One former White House official, who worked for Biden when he was vice president under President Barack Obama and as president, was treated by the same doctor for migraines in 2016, the former official told Reuters.

The doctor came to the White House once a month then as part of his rotation, the individual said.

White House spokesperson Karine Jean-Pierre refused to confirm or elaborate on Cannard's visits earlier in the day. At the media briefing, she was frequently challenged by reporters and said she wanted to respect the privacy of all involved for security reasons.

She said Biden had seen a neurologist three times connected to his annual physical exam. She did not explain Cannard's presence at the White House but suggested it might be connected to treating some of the military personnel who work at the White House complex.

"There are thousands of military personnel that come to the White House and they are under the care of the medical unit," she said.



Reporting by Andrea Shalal, Steve Holland and Jeff Mason; Writing by Doina Chiacu; Editing by David Gregorio, Heather Timmons, Deepa Babington, Cynthia Osterman and Himani Sarkar

</body></html>

면책조항: XM Group 회사는 체결 전용 서비스와 온라인 거래 플랫폼에 대한 접근을 제공하여, 개인이 웹사이트에서 또는 웹사이트를 통해 이용 가능한 콘텐츠를 보거나 사용할 수 있도록 허용합니다. 이에 대해 변경하거나 확장할 의도는 없습니다. 이러한 접근 및 사용에는 다음 사항이 항상 적용됩니다: (i) 이용 약관, (ii) 위험 경고, (iii) 완전 면책조항. 따라서, 이러한 콘텐츠는 일반적인 정보에 불과합니다. 특히, 온라인 거래 플랫폼의 콘텐츠는 금융 시장에서의 거래에 대한 권유나 제안이 아닙니다. 금융 시장에서의 거래는 자본에 상당한 위험을 수반합니다.

온라인 거래 플랫폼에 공개된 모든 자료는 교육/정보 목적으로만 제공되며, 금융, 투자세 또는 거래 조언 및 권고, 거래 가격 기록, 금융 상품 또는 원치 않는 금융 프로모션의 거래 제안 또는 권유를 포함하지 않으며, 포함해서도 안됩니다.

이 웹사이트에 포함된 모든 의견, 뉴스, 리서치, 분석, 가격, 기타 정보 또는 제3자 사이트에 대한 링크와 같이 XM이 준비하는 콘텐츠 뿐만 아니라, 제3자 콘텐츠는 일반 시장 논평으로서 "현재" 기준으로 제공되며, 투자 조언으로 여겨지지 않습니다. 모든 콘텐츠가 투자 리서치로 해석되는 경우, 투자 리서치의 독립성을 촉진하기 위해 고안된 법적 요건에 따라 콘텐츠가 의도되지 않았으며, 준비되지 않았다는 점을 인지하고 동의해야 합니다. 따라서, 관련 법률 및 규정에 따른 마케팅 커뮤니케이션이라고 간주됩니다. 여기에서 접근할 수 있는 앞서 언급한 정보에 대한 비독립 투자 리서치 및 위험 경고 알림을 읽고, 이해하시기 바랍니다.

리스크 경고: 고객님의 자본이 위험에 노출 될 수 있습니다. 레버리지 상품은 모든 분들에게 적합하지 않을수 있습니다. 당사의 리스크 공시를 참고하시기 바랍니다.